Setastine — CAS 116476-13-2

Setastine is a second-generation antihistamine with potent H1-receptor antagonist activity used for the symptomatic relief of allergic conditions. It demonstrates low CNS penetration, resulting in minimal sedation compared to classical antihistamines. Setastine is effective in managing urticaria, allergic rhinitis, and other IgE-mediated hypersensitivity reactions. Mediocon Inc manufactures GMP-certified Setastine API at its Aurangabad facility.

• Allergic rhinitis
• Urticaria and skin allergies
• IgE-mediated hypersensitivity
• Non-sedating antihistamine formulations

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support